Clinical Trials

Breast Neoplasms

NCT06086340 2025-11-18

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

779 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT05635357 2025-07-28

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

16,989 enrolled

Breast Neoplasms

NCT01814397 2024-02-07

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

50 enrolled 15 charts

Breast Neoplasms, Pain, Arthralgia

NCT00719966 2024-01-02

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

109 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02753686 2023-02-15

Treat ER+ight

440 enrolled

Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

1,000 enrolled

Breast Neoplasms

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

1,354 enrolled

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT04389424 2020-05-15

NUTRIBREAST

300 enrolled

BreastOther

Breast Neoplasms, Nutrition Disorders, Obesity, Vitamin D Deficiency

NCT02765373 2019-05-13

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

500 enrolled

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

300 enrolled

Breast Cancer Organoids

NCT01896050 2016-06-28

LOGRIBMET

115 enrolled 14 charts

BreastOther

Breast Neoplasms, Obesity, Arthralgia

NCT02023359 2015-12-29

Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

7 enrolled

Breast Neoplasms

NCT01047358 2015-10-08

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

206 enrolled 9 charts

Breast Neoplasms

NCT01121549 2014-01-22

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

378 enrolled 16 charts

Invasive Early Breast Cancer

NCT00776659 2013-11-19

An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin

39 enrolled 7 charts

Breast Neoplasms

NCT01239745 2012-10-31

Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

46 enrolled 9 charts

Breast Neoplasms

NCT01155063 2012-10-01

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

89 enrolled 12 charts

Breast Neoplasms

NCT01305239 2012-04-10

ETAPE

398 enrolled 10 charts

Breast Neoplasms

NCT01050634 2010-07-23

FAST

980 enrolled 10 charts

Post Menopausal Women With Early Breast Cancer

NCT00932165 2010-07-20

Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

451 enrolled 14 charts